Publikationen von Vladislav Yakimov

Falkai, P.; Wagner, E.; John, M.; Yakimov, V.; Galderisi, S.; Bitter, I.; Dom, G.; Schmitt, A.; Gaebel, W.; Carpiniello, B. et al.; Hasan, A.: Developing the EPA guidance of pharmacological treatment of schizophrenia - results of a Delphi process. EUROPEAN PSYCHIATRY 68 (1), e26 (2025)

Moussiopoulou, J.; Yakimov, V.; Roell, L.; Rauchmann, B.-S.; Toth, H.; Melcher, J.; Jager, I.; Lutz, I.; Kallweit, M. S.; Papazov, B. et al.; Boudriot, E.; Seelos, K.; Dehsarvi, A.; Campana, M.; Raabe, F.; Maurus, I.; Lohrs, L.; Brendel, M.; Stocklein, S.; Falkai, P.; Hasan, A.; Group, C. W.; Franzmeier, N.; Keeser, D.; Wagner, E.: Higher blood-brain barrier leakage in schizophrenia-spectrum disorders: A comparative dynamic contrast-enhanced magnetic resonance imaging study with healthy controls. Brain, behavior, and immunity 128, S. 256 - 265 (2025)

Boudriot, E.; Gabriel, V.; Popovic, D.; Pingen, P.; Yakimov, V.; Papiol, S.; Roell, L.; Hasanaj, G.; Xu, S.; Moussiopoulou, J. et al.; Priglinger, S.; Kern, C.; Schulte, E. C.; Hasan, A.; Pogarell, O.; Falkai, P.; Schmitt, A.; Schworm, B.; Wagner, E.; Keeser, D.; Raabe, F. J.: Signature of Altered Retinal Microstructures and Electrophysiology in Schizophrenia Spectrum Disorders Is Associated With Disease Severity and Polygenic Risk. BIOLOGICAL PSYCHIATRY 96 (10), S. 792 - 803 (2024)

Yakimov, V.; Moussiopoulou, J.; Roell, L.; Kallweit, M. S.; Boudriot, E.; Mortazavi, M.; Papiol, S.; Krčmář, L.; Campana, M.; Schulte, E. C. et al.; Glaichenhaus, N.; Martinuzzi, E.; Halstead, S.; Warren, N.; Siskind, D.; Maurus, I.; Hasan, A.; Falkai, P.; Schmitt, A.; Raabe, F.; Keeser, D.; Wagner, E.: Investigation of choroid plexus variability in schizophrenia-spectrum disorders-insights from a multimodal study. Schizophrenia (Heidelberg, Germany) 10 (1), 121 (2024)

Yakimov, V.; Moussiopoulou, J.; Hasan, A.; Wagner, E.: The common misconception of blood-brain barrier terminology in psychiatry and neurology. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2023)

Warren, N.; O'Gorman, C.; Horgan, I.; Weeratunga, M.; Halstead, S.; Moussiopoulou, J.; Campana, M.; Yakimov, V.; Wagner, E.; Siskind, D.: Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: A systematic review and meta-analysis of 69 studies with 5710 participants. SCHIZOPHRENIA RESEARCH 266, S. 24 - 31 (2024)